期刊文献+

钙激活酶激活蛋白基因的克隆及其在原核生物中表达及条件的优化 被引量:3

Cloning of Calpain Activator Gene and the Optimized Expression Condition in Prokaryotes
下载PDF
导出
摘要 构建钙激活酶激活蛋白基因(UK114)的原核表达载体并优化其表达条件,为其高效表达提供试验依据。以UK114 cDNA为模板,通过PCR方法扩增钙激活酶激活蛋白基因,将其克隆到原核表达载体pGEX-4T-3中,酶切及测序鉴定重组体。将构建好的重组质粒转化大肠埃希菌BL21(DE3),用IPTG进行诱导表达,在保持菌种不改变的前提下,分别改变IPTG的浓度、培养时间、菌体浓度、培养温度等来优化表达条件。结果显示,原核表达载体pGEX-4T-3-UK114成功构建,可在大肠埃希菌BL21(DE3)中诱导表达,得到相对分子质量约40 kD的GST-UK114融合蛋白。在IPTG浓度为0.3 mmol/L,诱导温度为32℃,诱导时间为4 h,菌体密度OD600为0.6的条件下,目的蛋白表达量最高。试验成功构建原核表达载体pGEX-4T-3-UK114且获高效表达,为研究UK114生物学活性及产品开发提供了试验基础。 :The aim of the study was designed to optimize Calpain activator(UK114) expression in prokaryotes for the high effective expression. The UKll4 cDNA was obtained by RT-PCR, and cloned into prokaryotic expression vector pGEX-4T-3-UK114, then recombinant vector pGEX 4T-3-UKl14 was constructed, and transformed into E. coli BL21 ( DE3). The expression of fusion protein GST-UK114 was induced with IPTG, then purified and characterized. The recombinant prokaryotic expression vector was successfully constructed by the restriction enzymes digestion and gene sequencing. Fusion protein GST-UK114 was expressed in solubility in E. coli BL21 (DE3)in SDS-PAGE gel. The content of fusion protein was 31% and the molecular weight was 40 kD. Through optimization, the satisfactory expression condi- tion was obtained, as follows, including IPTG concentration 0.3 mmol/L; induced time of 4 hours ; OD600 0.6 ; cultured temperature 32 ℃ The plasmid pGEX-4T-3-UK114 was successfully constructed and expressed in prokaryotes with high efficiency. The results provide a foundation for studing the biological activity of UK114 protein.
出处 《激光生物学报》 CAS CSCD 2012年第2期156-161,共6页 Acta Laser Biology Sinica
基金 山西省科技攻关项目(20090311037) 山西农业大学青年基金(2005027)
关键词 钙激活酶激活蛋白 原核表达 条件优化 calpain activator prokaryotic expression condition optimization
  • 相关文献

参考文献15

  • 1CORAL D E,D E MARTINO G N. Comparison of two calciumdependent proteinases from bovine heart [ J]. Biochemical and Biophysical Acta, 1984, 788:348-355.
  • 2常泓,南庆贤.钙激活酶激活蛋白的研究进展[J].肉类工业,2001(12):46-49. 被引量:6
  • 3MELLON E, MICHETTI M,SALAMI NO F,et al. Mechanism of action of a new component of the Ca2 + -dependent proteolytic system in rat brain: the Calpain activator[ J]. Biochemical and Biophysical Research Communications, 1998, 24(9) :583-588.
  • 4常泓,南庆贤,岳文斌.PCR法扩增钙激活酶激活蛋白cDNA[J].山西农业大学学报(自然科学版),2005,25(1):64-66. 被引量:5
  • 5CECILIANI F, FAOTTO L, NEGRI A,et al. The primary structure of UK114 tumor antigen [J]. FEBS Lett, 1996, 393:147- 150.
  • 6CARAAGHER N O. Calpain inhibition: A therapeutic strategy targeting multiple disease states [ J]. Curr Pharm Des, 2006, 12 (5) :615-638.
  • 7RAY S K. Currently evaluated calpain and caspase inhibitors for neuroprotection in experimental brain ischemia [ J]. Curr Med Chem, 2006, 13 ( 28 ) :3425-3440.
  • 8LEITNER-DAGAN Y, OVADIS M, ZUKER A, et al. CHRD, a plant member of the evolutionarily conserved YjgF family, influences photosynthesis and chromoplastogenesis [ J ]. Planta, 2006, 225:89-102.
  • 9DERIU D, BRIAND C, MISTINIENE E, et al. Structure and oligomeric state of the mammalian tumour associated antigen UK114 [ J ]. Acta Crystal logr Sect D Biol Crystallogr, 2003, 59: 1676-1678.
  • 10SINHA S, RAPPU P, LANGE S C, et al: Crystal structure of Bacillus subtilis YabJ, a purine regulatory protein and member of the highly conserved YjgF tamily[ J ]. Proc Natl Acad Sci USA, 1999, 96 : 13074-13079.

二级参考文献28

  • 1罗启慧,景志忠,于三科,窦永喜,陈国华,蒙学莲.长白猪IL-6基因的克隆及其序列分析[J].中国兽医科技,2005,35(2):129-133. 被引量:3
  • 2J.萨姆布鲁克 E.F弗里奇.分子克隆实验指南(第二版)[M].北京:科学出版社,1992.332-333.
  • 3Hu B,Coulson L,Moyer B,et al.Isolation and molecular cloning of a novel bone phosphoprotein related in sequence to the cystatin family of thiol protease inhibitors[J].The Journal of Biological Chemistry,1995,270(17):431-436.
  • 4Swallow J E,Merrison W K,Gill P K,et al.Assignment of secreted phosphoprotein 24 (SPP2) to human chromosome band 2q37-> qter by in situ hybridization[J].Cytogenetios and Cell Genetics,1997,79(1-2):142.
  • 5Bennett C S,Khorram Khorshid H R,Kitchen J A,et al.Character ization of the human secreted phosphoprotein 24 gene (SPP2) and comparison of the protein sequence in nine species[J].Matrix Biolo gy,2004,22(8):641-651.
  • 6GotoT,Yamaza T,Tanaka T.Cathepsins in the osteoclast[J].Jour nal of Electron Microscopy,2003,52(6):551-558.
  • 7Behnam K,Phillips M L,Silva J D,et al.BMP binding peptide:a BMP-2 enhancing factor deduced from the sequence of native bovine bone morphogenetic protein/non-collagenous protein[J].Journal of Orthopaedic Research,2005,23(1):175-180.
  • 8Sintuu C,Murray S S,Behnam K,et al.Full-length bovine spp24[spp24 (24-203)] inhibits BMP-2 induced bone formation[J].Journal of Orthopaedic Research,2008,26(6):753-758.
  • 9Price P A,Nguyen T M,Williamson M K.Biochemical characteriza tion of the serum fetuin-mineral complex[J].The Journal of Biologi cal Chemistry,2003,278(24):22153-22160.
  • 10Murray E J,Murray S S,Simon R,et al.Recombinant expression,isolation,and proteolysis of extracellular matrix-secreted phosphopro tein-24 kDa[J].Connective Tissue Research,2007,48(6):292-299.

共引文献12

同被引文献46

  • 1秦云,陈苏民,关路媛,陈南春,赵玮钦,宋庆贺.基因重组人骨形成蛋白4成熟肽在大肠杆菌中的大规模发酵表达及纯化[J].科学技术与工程,2005,5(6):337-341. 被引量:2
  • 2常泓,南庆贤,岳文斌.PCR法扩增钙激活酶激活蛋白cDNA[J].山西农业大学学报(自然科学版),2005,25(1):64-66. 被引量:5
  • 3刘永进,方开吉,刘志圣,田淑丽.网箱养殖罗非鱼暴发性鱼病及防治技术[J].淡水渔业,1995,25(1):25-26. 被引量:8
  • 4钟根深,石炳兴,王海东,蒋中华,吴祖泽.表达重组葡激酶-水蛭素融合蛋白的大肠杆菌工程菌的高密度培养[J].中国生物工程杂志,2006,26(9):11-15. 被引量:5
  • 5Rainard P,Boulard C. Opsonization of Streptococcusagalactiae of bovine origin by complement and anti-bodies against group B polysaccharide [J]. Infect Im-mun, 1992,60( 11) :4801-4808.
  • 6Bryan J D,Liles R,Cvek U,et al. Global transcrip-tional profiling reveals Streptococcus agalactiae genescontrolled by the MtaR transcription factor[J]. BMCGenomics,2008,16(9) :607.
  • 7Spellerberg B, Rozdzinski E,Martin S,et al. rgf en-codes a novel two-component signal transduction sys-tem of Streptococcus agalactiae [J]. Infect Immun,2002,70(5):2434-2440.
  • 8Fisher S H. Regulation of nitrogen metabolism in Ba-cillus subtilis; vive la differenceQ]. Mol. Microbiol.1999,32(2):223-232.
  • 9Nakano Y,Kimura K. Purification and characteriza-tion of a repressor for the Bacillus cereus glnRA oper-on[J]. J. Biochem.,1991,109(2):223-228.
  • 10Gustafson J,Str ssle A,H chler H, et al. The femClocus of Staphylococcus aureus required for Met-hicil-lin resistance includes the glutamine synthetase oper-on[J].J. Bacteriol.,1994,176(5) : 1460-1467.

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部